Amicus Therapeutics, Inc. (FOLD) is a leading biopharmaceutical innovator headquartered in Philadelphia, Pennsylvania, focused on the development of advanced therapies for rare metabolic disorders. Leveraging its proprietary enzyme replacement therapy platform, Amicus excels in personalized medicine by providing customized treatment solutions for patients with critical unmet medical needs. The company has a robust pipeline concentrated on innovative therapies for lysosomal storage disorders, underlining its commitment to improving health outcomes in rare diseases and reinforcing its influential role within the biotechnology sector. Show more

Location: 47 HULFISH STREET, PRINCETON, NJ, UNITED STATES, 08542, Princeton, NJ, 08542, USA | Website: https://amicusrx.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

4.483B

52 Wk Range

$5.51 - $14.38

Previous Close

$14.27

Open

$14.27

Volume

4,742,885

Day Range

$14.27 - $14.29

Enterprise Value

4.656B

Cash

190.6M

Avg Qtr Burn

N/A

Insider Ownership

0.57%

Institutional Own.

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Galafold (migalastat) Details Fabry disease	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) Details Pompe Disease	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
DMX-200 (CCR2 Antagonist) Details Focal Segmental Glomerulosclerosis	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AT-GTX-501 Details Batten Disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AT-GTX-502 Details Batten Disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.